In HF with mildly reduced or preserved ejection fraction, finerenone reduced worsening HF or CV death at 32 mo.

MLA

Chitsazan, Mitra, and Harriette G. C. Van Spall. “In HF with Mildly Reduced or Preserved Ejection Fraction, Finerenone Reduced Worsening HF or CV Death at 32 Mo.” Annals of Internal Medicine, vol. 178, no. 1, Jan. 2025, p. JC2. EBSCOhost, https://doi.org/10.7326/ANNALS-24-03365-JC.

APA

Chitsazan, M., & Van Spall, H. G. C. (2025). In HF with mildly reduced or preserved ejection fraction, finerenone reduced worsening HF or CV death at 32 mo. Annals of Internal Medicine, 178(1), JC2. https://doi.org/10.7326/ANNALS-24-03365-JC

Chicago

Chitsazan, Mitra, and Harriette G.C. Van Spall. 2025. “In HF with Mildly Reduced or Preserved Ejection Fraction, Finerenone Reduced Worsening HF or CV Death at 32 Mo.” Annals of Internal Medicine 178 (1): JC2. doi:10.7326/ANNALS-24-03365-JC.